Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein R695 (MIMI_R695) is a protein derived from the Acanthamoeba polyphaga mimivirus (APMV). MIMI_R695 is considered an uncharacterized protein, meaning its specific function within the virus is not yet fully understood .
| Characteristic | Description |
|---|---|
| Name | Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein R695 (MIMI_R695) |
| Source Organism | Acanthamoeba polyphaga mimivirus (APMV) |
| Product Type | Recombinant Protein |
| Uniprot ID | Q5UNW0 |
| Amino Acid Sequence | MATNTSSNLLTNPYTEREKKLIDEAYYRDLKYNLTSKSRWKFIGDVSETLSQICVGTSSVLAFASGFFEDIDILAFVAGTVGVGSLVLLQFSSYAMKESSERTQQVNVILTKLGLETIPDIVVEPSIIKARLQGELGEQENDVVIEV |
| Expression Region | 1-147 amino acids |
As an uncharacterized protein, MIMI_R695 may be a subject of interest in research aimed at elucidating the functions and mechanisms of large viruses like APMV. Further studies are needed to determine the precise role of MIMI_R695 in the viral life cycle or its interactions with the host.
| Guideline | Description |
|---|---|
| Clear Title | The title should clearly and concisely describe the content of the table. |
| Descriptive Column Headings | Column headings should accurately indicate the nature of the data presented in each column, including units of measurement. |
| Self-Explanatory | Tables should be designed to be understandable on their own, without requiring reference to the main text. |
| Relevant Data | Only include data that is relevant to the research question(s) and objectives. |
| Appropriate Formatting | Use consistent formatting throughout the table, including the number of decimal places and the alignment of data. |
| Avoid Redundancy | Do not repeat data from the text in the tables; instead, use tables to provide more detailed or specific information. |
| Statistical Information | If applicable, include relevant statistical information such as means, standard deviations, and p-values in the table or in footnotes. |
| Footnotes | Use footnotes to explain abbreviations, symbols, or any other information necessary to understand the table. |
| Ethical Considerations | Ensure that the presentation of data in tables adheres to ethical guidelines, including protecting the privacy of participants and avoiding any misrepresentation of the data. |
| Accessibility | Design tables to be accessible to all readers, including those with disabilities. This may involve using appropriate color contrasts and providing alternative text descriptions for screen readers. |
KEGG: vg:9925347
MIMI_R695 is one of many ORFan proteins (proteins with no detectable homologs in other organisms) encoded by the mimivirus genome. Proteomic analyses of mimivirus have identified 114 distinct proteins incorporated into the viral particle, demonstrating that many ORFan gene products contribute to the structure of the mimivirus particle .
While some ORFan proteins like MIMI_L724 and MIMI_L725 have been shown to have antigenic properties and are located on the surface of the viral particle, MIMI_R695 has not yet been specifically characterized in terms of its location or function in the viral structure . Understanding MIMI_R695 could provide insights into the unique biology of mimiviruses and their evolutionary history.
Based on current research protocols, E. coli has been successfully used as an expression system for MIMI_R695. The protein can be expressed with an N-terminal His-tag to facilitate purification . The typical expression workflow includes:
Codon optimization for bacterial expression
Subcloning into an appropriate expression vector
Transformation into an E. coli strain such as BL21(DE3)
Induction of protein expression
Purification using affinity chromatography
When designing an expression strategy, researchers should consider:
| Expression System | Advantages | Limitations | Best For |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid growth | Limited post-translational modifications | Basic structural studies, antibody production |
| Yeast | Some eukaryotic post-translational modifications | Moderate yield | Functional studies requiring glycosylation |
| Insect cells | Better eukaryotic post-translational modifications | Higher cost, longer production time | Studies requiring folding similar to viral environment |
| Mammalian cells | Most authentic post-translational modifications | Highest cost, most complex system | Interaction studies with host factors |
For most basic characterization studies, E. coli expression has proven sufficient for MIMI_R695 .
For characterizing uncharacterized proteins like MIMI_R695, a quasi-experimental approach with appropriate controls is recommended. Based on the literature on experimental design in medical informatics and virology research, a combination of approaches yields the most robust results :
Comparative proteomics studies: Compare the expression patterns of MIMI_R695 under different conditions (e.g., different stages of viral infection).
Localization studies: Use immunogold labeling with antibodies against MIMI_R695 to determine its location within the viral particle or infected cells, similar to studies done with MIMI_L725 .
Protein-protein interaction studies: Employ co-immunoprecipitation, yeast two-hybrid, or pull-down assays to identify proteins that interact with MIMI_R695.
Functional genomics approach: Use gene knockout or knockdown techniques followed by phenotypic analysis.
The strongest experimental design would include:
| Quasi-experimental Design Type | Design Notation | Application to MIMI_R695 Research |
|---|---|---|
| Untreated control group with dependent pretest and posttest samples | Intervention group: O1a X O2a Control group: O1b O2b | Compare wild-type mimivirus with MIMI_R695 mutants |
| Multiple pretest and posttest observations | O1 O2 O3 O4 O5 X O6 O7 O8 O9 O10 | Track MIMI_R695 expression throughout viral infection cycle |
Where O = Observational Measurement and X = Intervention Under Study .
Recombinant MIMI_R695 expressed with a His-tag can be effectively purified using the following protocol:
Cell lysis in Tris/PBS-based buffer
Nickel affinity chromatography for primary purification
Size exclusion chromatography for further purification
Quality assessment via SDS-PAGE (aim for >90% purity)
Storage in Tris/PBS-based buffer with 6% Trehalose, pH 8.0
For long-term storage, it is recommended to add 5-50% glycerol and aliquot for storage at -20°C/-80°C. Repeated freeze-thaw cycles should be avoided, and working aliquots can be stored at 4°C for up to one week .
The protein can be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL. For experiments requiring high purity, additional purification steps such as ion exchange chromatography may be necessary.
To comprehensively characterize MIMI_R695, several complementary analytical techniques should be employed:
Structural Analysis:
X-ray crystallography or cryo-EM for tertiary structure
Circular dichroism (CD) for secondary structure elements
Mass spectrometry for post-translational modifications
Functional Analysis:
Glycosylation analysis using GlycoProfile III fluorescence assay
Enzymatic activity assays based on predicted functions
Western blot with patient sera to assess antigenicity
Interaction Analysis:
For a comprehensive proteomic analysis, a combination of 1D electrophoresis coupled with LC-MS/MS and 2D gels coupled to MALDI-TOF-MS is recommended, as this approach eliminates methodological deficiencies encountered in separating low-abundance and hydrophobic proteins .
When analyzing data related to uncharacterized proteins like MIMI_R695, a systematic approach is essential:
Sequence analysis:
Compare to other mimivirus proteins
Conduct in silico functional prediction using tools like BLAST, InterProScan, and PFAM
Analyze for conserved domains, transmembrane regions, and signal peptides
Experimental data analysis:
Visualization and reporting:
| Table Type | Contribution to Research | Example Application for MIMI_R695 |
|---|---|---|
| Data source table | Facilitates assessment of data credibility | List all experimental approaches used to characterize MIMI_R695 |
| Concept-evidence table | Grounds interpretations in empirical evidence | Present evidence for putative functions of MIMI_R695 |
| Cross-case analysis table | Facilitates systematic comparisons | Compare MIMI_R695 characteristics with other mimivirus proteins |
| Temporally ordered table | Tracks empirical support for temporal patterns | Document MIMI_R695 expression during viral infection stages |
For uncharacterized proteins like MIMI_R695, bioinformatic prediction can provide valuable hypotheses about function:
Sequence-based prediction:
Homology detection using sensitive methods like HHpred or HMMER
Secondary structure prediction using PSIPRED
Disorder prediction using IUPred2A
Transmembrane topology prediction using TMHMM
Structure-based prediction:
Ab initio structure prediction using AlphaFold2 or RoseTTAFold
Molecular dynamics simulations to identify potential binding pockets
Docking studies with potential ligands or interaction partners
Functional annotation:
Gene Ontology term prediction based on structure
Network-based function prediction using known viral-host protein interactions
Comparison with other mimivirus proteins of known function
These predictions should be used to design targeted experiments for validation, creating an iterative process between computational prediction and experimental verification.
While the specific function of MIMI_R695 remains unknown, research on other mimivirus proteins suggests potential roles:
Structural component: Many ORFan proteins in mimivirus serve as structural components of the viral particle .
Host interaction: MIMI_R695 might interact with host factors to facilitate virus entry or replication, similar to other viral proteins.
Enzymatic activity: The protein sequence might harbor cryptic enzymatic functions, as seen with other initially uncharacterized viral proteins.
Immune evasion: Some viral proteins function to evade or suppress host immune responses.
To investigate these possibilities, researchers could employ a transfection approach similar to that used in a study where mimivirus DNA was transfected into Acanthamoeba castellanii to generate infectious virions . This study revealed the need for at least four uncharacterized proteins (L442, L724, L829, and R387) for DNA-mediated APMV generation. MIMI_R695 could be included in similar knockout studies to assess its importance in viral replication.
Post-translational modifications (PTMs) could significantly impact MIMI_R695 function. Mimivirus contains six ORFs encoding putative glycosyltransferases and likely provides its own glycosylation machinery . 2D gel profiles of mimivirus proteins have revealed cleaved proteins and various isoforms due to protein glycosylation.
To investigate PTMs in MIMI_R695:
Use mass spectrometry to identify potential modification sites
Apply glycosylation-specific staining methods like GlycoProfile III fluorescence assay
Compare E. coli-expressed MIMI_R695 (minimal PTMs) with protein expressed in eukaryotic systems
Examine the impact of PTMs on protein-protein interactions and localization
Understanding these modifications could provide crucial insights into the protein's function and regulation within the viral life cycle.
To investigate the potential antigenic properties of MIMI_R695, researchers could employ approaches similar to those used for MIMI_L724 and MIMI_L725 :
Immunization studies:
Immunize mice with purified recombinant MIMI_R695
Collect sera and test reactivity against the recombinant protein using ELISA and Western blotting
Analyze cross-reactivity with other mimivirus proteins
Epitope mapping:
Generate a panel of overlapping peptides covering the MIMI_R695 sequence
Identify specific epitopes recognized by antibodies
Determine if these epitopes are accessible on the surface of the viral particle
Immunogold electron microscopy:
Human sera testing:
Screen sera from individuals with confirmed Acanthamoeba polyphaga mimivirus exposure
Test reactivity against recombinant MIMI_R695
Compare with reactivity against other mimivirus proteins of known antigenicity
To understand MIMI_R695 within the broader context of the mimivirus proteome, researchers should:
Comparative proteomics:
Compare the expression pattern of MIMI_R695 with other mimivirus proteins during different stages of infection
Use quantitative proteomics (e.g., SILAC or TMT labeling) to track changes in abundance
Protein interaction networks:
Perform immunoprecipitation followed by mass spectrometry to identify interaction partners
Construct a protein-protein interaction network including MIMI_R695
Use this network to infer potential functions based on the "guilt by association" principle
Gene knockout studies:
Create mimivirus variants with MIMI_R695 knocked out or mutated
Assess the impact on viral replication, structure, and infectivity
Compare with knockouts of other mimivirus proteins to identify functional relationships
Evolutionary analysis:
Compare MIMI_R695 across different mimivirus strains and related giant viruses
Identify conserved regions that might indicate functional importance
Reconstruct the evolutionary history of this protein within the context of mimivirus evolution
This multi-layered approach would provide a comprehensive understanding of MIMI_R695's role in the viral life cycle and potentially reveal unexpected functions or interactions.
Based on current knowledge and technological capabilities, several research directions show particular promise:
Structural biology approaches:
Determining the high-resolution 3D structure of MIMI_R695 using X-ray crystallography or cryo-EM
Using structural information to predict function and potential interaction partners
Systems biology integration:
Incorporating MIMI_R695 into comprehensive models of mimivirus infection
Understanding its place within viral-host interaction networks
Evolutionary analysis:
Searching for distant homologs in other giant viruses or cellular organisms
Tracing the evolutionary history and potential functional shifts
Functional genomics:
CRISPR-based screens to identify host factors that interact with MIMI_R695
Viral genetic manipulation to understand the protein's role in viral fitness
Translational applications:
Exploring potential diagnostic applications if MIMI_R695 proves immunogenic
Investigating whether MIMI_R695 could be a target for antiviral interventions
These approaches, especially when combined, offer the potential to transform our understanding of this uncharacterized protein and contribute to broader knowledge about mimivirus biology.
Several methodological challenges remain in studying MIMI_R695:
Expression and purification optimization:
Ensuring proper folding and post-translational modifications
Scaling up production for structural studies
Functional assay development:
Creating specific assays without prior knowledge of function
Avoiding false positives in interaction studies
Genetic manipulation of mimiviruses:
Efficiently generating gene knockouts or modifications
Separating direct from indirect effects in complex viral systems
Computational prediction limitations:
Addressing the lack of close homologs for comparative analysis
Validating in silico predictions experimentally
Experimental design constraints:
Overcoming these challenges will require innovative approaches and potentially the development of new methodologies specific to giant virus research.